Osteoporosis Is Associated With High Risk for Coronary Heart Disease A Population-Based Cohort Study

被引:46
作者
Chen, Sy-Jou [1 ]
Lin, Chin-Sheng [2 ]
Lin, Cheng-Li [3 ,4 ]
Kao, Chia-Hung [5 ,6 ,7 ,8 ]
机构
[1] Natl Def Med Ctr, Triserv Gen Hosp, Dept Emergency Med, Taipei, Taiwan
[2] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan
[3] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan
[4] China Med Univ, Coll Med, Taichung 404, Taiwan
[5] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung 404, Taiwan
[6] China Med Univ, Coll Med, Sch Med, Taichung 404, Taiwan
[7] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan
[8] China Med Univ Hosp, PET Ctr, Taichung, Taiwan
关键词
BONE-MINERAL DENSITY; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; VASCULAR CALCIFICATION; POSTMENOPAUSAL WOMEN; ATHEROSCLEROSIS; MEN; OSTEOPROTEGERIN; PATHOGENESIS; LIPOPROTEIN;
D O I
10.1097/MD.0000000000001146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We employed a population-based cohort sample to explore the risk of coronary heart disease (CHD) in relation to osteoporosis in an Asian population. We designed a retrospective population-based cohort study from 2000 to 2010 with data obtained from Taiwan's Longitudinal Health Insurance Database. A total of 19,456 patients aged 45 years or older who had no history of CHD and had a diagnosis of osteoporosis were identified as the osteoporosis cohort. The patients in the comparison cohort were randomly selected and frequency matched according to age, sex, and year of index date at a 1:1 ratio. Both cohorts were followed from the index date until a new diagnosis of CHD was made. Baseline variables, comorbidities, and bisphosphonate and estrogen prescriptions were collected. The overall incidence of CHD was 23.5 (per 1000 person-years) for the osteoporosis cohort and 16.7 for the comparison cohort, with a mean follow-up of 6.54 years and 6.63 years, respectively. The hazard ratio (HR) for developing CHD during follow-up was 1.30 (95% confidence interval [CI], 1.23-1.38) for the osteoporosis cohort compared with the comparison cohort after adjusting for age, sex, comorbidities, and estrogen medication. Patients with osteoporosis who received treatment with bisphosphonates or with both bisphosphonates and estrogen exhibited a significantly lower risk for CHD (adjusted HR = 0.37 and 0.23) than those who did not receive either of these 2 medications. The results support an association between osteoporosis and CHD in Asian population.
引用
收藏
页数:6
相关论文
共 43 条
[41]   Coronary calcification score: the coronary-risk impact factor [J].
Thompson, GR ;
Partridge, J .
LANCET, 2004, 363 (9408) :557-559
[42]   Atherosclerosis: current pathogenesis and therapeutic options [J].
Weber, Christian ;
Noels, Heidi .
NATURE MEDICINE, 2011, 17 (11) :1410-1422
[43]   THE RESPONSE-TO-RETENTION HYPOTHESIS OF EARLY ATHEROGENESIS [J].
WILLIAMS, KJ ;
TABAS, I .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (05) :551-561